A large part is investment. It is also about understanding that we need to have the right business conditions in order to support our companies. It means having different types of regulatory support as well.
We commissioned a study at the end of December that looks at governance and the gap of translation that exists in Canada. There really is a need for our innovators and our companies to more readily access Health Canada, for example. One of the recommendations we made in that study is a concierge service where assistance is provided to innovators to provide them with guidance on how to navigate the regulatory ecosystem at Health Canada and the CDA, ultimately to ensure that their products are sold here.